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Abstract
Background: The early diagnosis of atherosclerotic disease is essential for developing preventive strategies in
populations at high risk and acting when the disease is still asymptomatic. A low ankle-arm index is a good marker
of vascular events and may be diminished without presenting symptomatology (silent peripheral arterial disease).
The aim of the study is to know the prevalence and associated risk factors of peripheral arterial disease in the
general population.
Methods: We performed a cross-sectional, multicentre, population-based study in 3786 individuals >49 years,
randomly selected in 28 primary care centres in Barcelona (Spain). Peripheral arterial disease was evaluated using
the ankle-arm index. Values < 0.9 were considered as peripheral arterial disease.
Results: The prevalence (95% confidence interval) of peripheral arterial disease was 7.6% (6.7-8.4), (males 10.2%
(9.2-11.2), females 5.3% (4.6-6.0); p < 0.001).
Multivariate analysis showed the following risk factors: male sex [odds ratio (OR) 1.62; 95% confidence interval 1.01-
2.59]; age OR 2.00 per 10 years (1.64-2.44); inability to perform physical activity [OR 1.77 (1.17-2.68) for mild limita-
tion to OR 7.08 (2.61-19.16) for breathless performing any activity]; smoking [OR 2.19 (1.34-3.58) for former smokers
and OR 3.83 (2.23-6.58) for current smokers]; hypertension OR 1.85 (1.29-2.65); diabetes OR 2.01 (1.42-2.83); previous
cardiovascular disease OR 2.19 (1.52-3.15); hypercholesterolemia OR 1.55 (1.11-2.18); hypertriglyceridemia OR 1.55
(1.10-2.19). Body mass index ≥25 Kg/m
2 OR 0.57 (0.38-0.87) and walking >7 hours/week OR 0.67 (0.49-0.94) were
found as protector factors.
Conclusions: The prevalence of peripheral arterial disease is low, higher in males and increases with age in both
sexes. In addition to previously described risk factors we found a protector effect in physical exercise and
overweight.
Background
The prevention and early diagnosis of atherosclerotic
disease is one of the essential objectives in the field of
cardiovascular disease since it is the main cause of mor-
tality in developed countries. In the European Union
these diseases represent approximately 40% of the
deaths in both men and women [1]. Atherosclerosis is
currently considered a chronic, progressive systemic
disease of multifactorial aetiology [2] including arterial
hypertension, hypercholesterolemia, diabetes mellitus
and smoking as modifiable risk factors and age and sex
as non modifiable factors [3]. These factors have been
integrated in prediction tables based on regression mod-
els with the aim of detecting the population with a high
risk of cardiovascular events [4]. However, the sensitivity
and positive predictive value of these tables is low, and
thus, most cardiovascular disease are produced in sub-
jects without a high risk [4]. It is therefore important to
develop markers of silent atherosclerotic disease which
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oping peripheral arterial disease in order to implement
preventive measures. In addition, atherosclerotic disease
remains clinically silent during most of the evolutionary
process until phenomena of complications of atheroma
plaques suddenly appear and lead to ischaemic vascular
events. Therefore, from a primary prevention point of
view, it is very important to develop strategies which
allow identification of patients with atherosclerosis in
subclinical stages, with primary care being the optimum
setting for accessibility.
Peripheral arterial disease is a common manifestation
of atherosclerosis and is characterized by increasing
incidence of morbi-mortality [5]. Peripheral arterial dis-
ease is a powerful predictor of cardio and cerebrovascu-
lar events and is associated with an increase in mortality
o fu pt o3 0 %a t5y e a r sa n d5 0 %a t1 0y e a r s[ 5 - 7 ]
thereby making early detection of this disease
fundamental.
The prevalence of peripheral arterial disease varies
greatly depending on the population studied, on the
definition of peripheral arterial disease used (sympto-
matic or not), the diagnostic method, age, sex and the
presence of other risk factors. Most studies have been
carried out in populations at high risk, with few having
been performed in countries of low risk [8-16]. The pre-
valence of peripheral arterial disease in countries with
low cardiovascular risk is uncertain.
Underdiagnosis of peripheral arterial disease is very
high since a very large proportion of these patients is
asymptomatic [17]. The ankle-arm index is the most
effective tool used to screen for peripheral arterial dis-
ease [18,19]. Compared with angiography, an ankle arm
index <0.9 presents a sensitivity of 95% and a specificity
of 99% for the detection of stenosis ≥50% [20], with the
reliability of this test being good when performed by
trained personnel [18-21].
The wide range of prevalence reported in the litera-
ture and the low number of studies in countries of low
risk such as Spain led to the design of this study, the
aim of which was to know the prevalence of peripheral
arterial disease using the calculation of the ankle arm
index in a general population over the age of 49 years
and to determine the risk factors associated with a
pathologic ankle arm index.
Methods
A detailed description of the methodology of the study
has been published elsewhere [22].
Briefly, this was a cross-sectional, multicentre, descrip-
tive, population-based study aim at determining the pre-
valence of symptomatic and asymptomatic peripheral
arterial disease and related factors in a general popula-
tion ascribed in primary care. Individuals were randomly
selected (simple random sampling) from a database,
which is more exhaustive and updated than the census,
containing the population ascribed in the centers parti-
cipating in the study. The randomly selected individuals
were invited to participate in the study by phone. If the
individuals were not found, up to 5 calls were made at
different hours and days of the week to contact them.
After agreement to participate subjects were given an
appointment to perform an interview, blood sample
extraction and anthropometric measurements, including
ankle-arm index.
A total of 28 primary healthcare centers within the
metropolitan area of the city of Barcelona and the
county of Barcelonès Nord-Maresme, including urban
and semi-rural centers, participated in the study. Finally,
from September 2006 to June 2008, a total of 3786
patients over the age of 49 years were included in the
study.
Data collection
The ankle arm index examination of the subjects was
carried out in the participating centres by two health-
care professionals trained in the technique, under stan-
dardized conditions. A standardized Doppler Ultrasonic
device was used (Mini-Dopplex D 900-P, Huntleigh
Healthcare, 8 MHz). Ankle-arm index was performed in
the two paramaleolar arteries of both lower extremities.
For each leg the ankle-arm index was the ratio of the
higher of the two systolic pressures (tibial posterior and
anterior artery) and arm systolic pressure using the sys-
tolic pressure of the highest arm. If the ankle-arm index
was < 0.9 the technique was performed by the other
professional. In cases in which the second professional
found an ankle arm index ≥ 0.9 the first repeated the
test and the latter value was considered as the final
result.
The following variables were collected: demographic
and lifestyle, including smoking and physical activity
with a validated questionnaire, self-reported and clinical
history of previous cardiovascular disease (acute myocar-
dial infarction, angina, stroke and transient ischaemic
attack), intermittent claudication, hypercholesterolemia,
diabetes mellitus, arterial hypertension; anthropometric
variables (height, weight, and waist circumference),
blood analysis (total cholesterol, HDL-cholesterol, trigly-
cerides, and glycaemia); cardiovascular risk using the
Framingham-Wilson equations, Framingham calibrated
by the REGICOR and SCORE groups; metabolic syn-
drome (NCEP criteria) [23]; and the Edinburgh vascular
questionnaire [8,15].
Statistical analysis
The prevalence of peripherala r t e r i a ld i s e a s ew a sc o m -
puted in the whole sample. However, patients with
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>1.4 (arterial calcification) were excluded from further
analyses involving potential associated risk factors with
peripheral arterial disease. Comparison of categorical
variables was performed using chi squared tests and for
continuous variables the t-test was used. In addition,
non parametric tests were used when distribution
requirements of the variables analyzed were not fulfilled.
Logistic regression models (LRM) were adjusted using
peripheral arterial disease as the dependent variable.
The individual effect, measured with the odds ratios
[OR, (95% confidence interval)] of the potential risk fac-
tors, was studied in age- and sex-adjusted LRM. Multi-
variate LRM were thereafter constructed to assess the
independent effects of each variable adjusted for the
other in the model. Best models were selected taking
into account the correlation between variables and the
Akaike Information Criteria (AIC) [24]. Only variables
with p < 0.05 remained in the model. Significance was
defined with a p value less than 0.05. All tests were
bilateral. Analysis was performed using Stata version 10
(StataCorp, College Station, TX, USA, 2007).
Ethics
This study was approved by the local Ethics Committee
(IDIAP Jordi Gol Foundation of Investigation in Primary
Care and Instituto de Salud Carlos III). Informed writ-
ten consent was obtained from all the participants. Like-
wise, the recommendations of the World Medical
Association Declaration of Helsinki were follow.
Ethical considerations
The authors of this manuscript have certified that they
comply with the Principles of Ethical Publishing in
BMC Public Health.
Results
The percentage of participation in the study was of 63%,
with 3786 participants >49 years [1746 men (46.1%) and
2040 women (53.9%)] with a mean age of 64.9 years ±
8.9 being included. Of these, 286 patients had an ankle-
arm index < 0.9. The prevalence of peripheral arterial
disease in the total population was 7.6% (95% confidence
interval 6.7-8.4) (men 10.2% (9.2-11.2), women 5.3%
(4.6-6.0); p < 0.001). For each 10 years of increased age,
the prevalence of peripheral arterial disease doubled.
Figure 1. Arterial calcification was diagnosed in 235
patients, representing 6.2% (5.5-7.0) of the patients
(men: 8.5% (7.6-9.4), women: 4.2% (3.6-4.8); p < 0.001)
who were excluded from the analysis of the factors asso-
ciated with peripheral arterial disease.
Table 1 describes the sample, excluding the patients
with arterial calcification according to whether periph-
eral arterial disease was present or not. Intermittent
claudication was present in 10.0% of the subjects. Only
19.0% of the patients with peripheral arterial disease had
been previously diagnosed. Of those who had not been
previously diagnosed 29.3% presented symptoms of IC.
More than 36.8% of the subjects presented obesity.
Most of the patients were classified as having low or
intermediate cardiovascular risk according to the tables,
while 10.8% had already presented cardiovascular
disease.
Risk factors for the presence of peripheral arterial disease
according to logistic regression analysis
Table 2 shows the results of the individual analysis of
the risk factors associated with the presence of periph-
eral arterial disease according to the LRM adjusted for
age, sex and centre and table 3 describes the results of
the multivariate analysis according to gender. Walking
more than 7 hours weekly (OR 0.67) and overweight/
obesity (OR 0.57) were protector factors on multivariate
analysis, although on stratification by sex, they were
only statistically significant in women. Male gender (OR
1.62), age (OR 2.00 per 10 years), difficulty in perform-
ing physical exercise (OR 7.08 breathlessness performing
any activity) and smoking (OR 3.83 for current smokers)
were positively associated with peripheral arterial disease
in both sexes. Hypertension (OR 1.85), diabetes
(OR 2.01) and previous CDV (OR 2.19) were associated
with peripheral arterial disease overall and among men,
and hypercholesterolemia (OR 1.55) and high triglycer-
ides (OR 1.55) were associated with peripheral arterial
disease overall and among women only. Variables only
significant for one gender in the multivariate analysis
showed a similar trend in both sexes. Although educa-
tion, occupation and IC were associated with peripheral
arterial disease in the age- and sex-adjusted models,
these factors had no significant effect in the multivariate
models. Stroke, transient ischaemic attack, angina or
and myocardial infarction were related to peripheral
arterial disease in the age- and sex-adjusted model but
were collapsed into a single cardiovascular disease vari-
able in the multivariate model providing better AIC
indexes. Information regarding cardiovascular disease
risk tables or metabolic syndrome was not included in
the multivariate model since most of their components
were already included. Nevertheless, a significant asso-
ciation (table 2) was observed between the metabolic
syndrome and peripheral arterial disease [OR 1.79
CI 95% (1.36-2.36)] and these variables showed a posi-
tive and significant association with peripheral arterial
disease in the age and sex adjusted models.
Discussion
The results of the present study indicate that the preva-
lence of peripheral arterial disease using the ankle-arm
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risk such as Spain in relation to other countries with a
higher risk [8-13]. Thus, our results coincide with stu-
dies which have reported lower values of cardiovascular
disease such as ischaemic heart disease [25]. In another
Spanish study [15], the prevalence of peripheral arterial
disease was lower (4.5%). Nonetheless, the age of the
subjects studied was from 35 to 79 years which could
explain the difference with our results considering that
it is well known that the prevalence of cardiovascular
disease increases with age [7].
The prevalence of peripheral arterial disease in the
general population is not well known in countries of
low risk. In Spain, all the previous studies have been
undertaken in populations at high risk or well selected
for different factors: male sex, smokers, diabetics, meta-
bolic syndrome or previous cardiovascular disease. In
these studies the prevalence ranged from 3.9% to 26.2%
according to the population studied [25-30], with the
high prevalence among hospitalized (26.2%) [27] and
diabetic patients (21.4%) [30] being of note. The low
prevalence of peripheral arterial disease in countries
with low cardiovascular risk [25] but a high prevalence
of cardiovascular risk factors (French paradox) could be
explained by protective factors in Mediterranean
countries, such as dietetic factors. Studies in Spain have
confirmed this low prevalence of peripheral arterial dis-
ease [15,16], coronary heart disease [31,32] and stroke
[33,34] compared with studies conducted in Northern
Europe.
One alarming data of our study was the under diagno-
sis of peripheral arterial disease of 81.0% which, accord-
ing to some authors, may be attributed to the large
number of patients (80-90%) who remain asymptomatic
and that the ankle arm index is not routinely evaluated
in primary care offices. It is important to note that in
the present study 33.8% of the patients with a pathologic
ankle arm index presented clinical manifestations of IC,
as defined by the Edinburgh questionnaire [8,35,36].
The patients may attribute this symptomatology to
other diseases or pathological processes. In most of the
studies published, the IC values among patients with
peripheral arterial disease were between 5% and 29.6%
[10,12], with the exception of the study by Coni et al.
[37] in which the prevalence of IC was very high
( 3 7 . 5 % )a n ds i m i l a rt ot h a to fo u rs t u d y ,a l t h o u g h ,i n
contrast with the previous study, we used the Edinburgh
questionnaire.
The proportion of patients with arterial calcification
was of note (6.2%). Its clinical significance has been
Figure 1 Prevalence of peripheral arterial disease and 95% confidence interval by age and sex.
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PAD
n = 286
Control
a
n = 3265
p-value
b
Gender < 0.001
Men 11.1 (178) 88.9 (1419)
Women 5.5 (108) 94.5 (1846)
Age (years) (mean ± SD) 70.70 ± 9.26 64.22 ± 8.60 < 0.001
Education < 0.001
Illiterate 14.2 (30) 85.8 (182)
Primary school 8.1 (196) 91.9 (2229)
Secondary school 5.4 (27) 94.6 (477)
High school 5.7 (7) 94.3 (116)
University 3.4 (4) 96.6 (112)
Occupation status < 0.001
Currently working 3.6 (30) 96.4 (813)
Housewife 4.7 (34) 95.3 (689)
Retired 12.2 (192) 87.8 (1380)
Unemployed 3.9 (6) 96.1 (148)
Disabled 11.1 (15) 88.9 (120)
Other 6.3 (3) 93.8 (45)
Ability to perform physical activity < 0.001
No limitation 3.8 (51) 96.2 (1291)
Mild limitation 8.5 (150) 91.5 (1618)
Only able to do light activity 19.9 (72) 80.1 (289)
Breathless with any activity 29.3 (12) 70.7 (29)
Walking (hours/week) 0.376
0-3 7.2 (65) 92.8 (844)
>3-7 8.0 (61) 92.0 (697)
>7 6.4 (86) 93.6 (1252)
Tobacco smoking < 0.001
Never smoker 5.3 (104) 94.7 (1871)
Former smoker 11.3 (108) 88.7 (844)
Current smoker 11.9 (74) 88.1 (550)
Claudication (people with leg pain when walking and no pain when stop) < 0.001
No 5.9 (184) 94.1 (2952)
Yes 26.9 (94) 73.1 (255)
Obesity 0.164
Underweight/Average (BMI<25) 9.7 (61) 90.3 (566)
Overweight (25≤BMI<30) 7.3 (118) 92.7 (1496)
Obese (BMI ≥ 30) 8.2 (107) 91.8 (1198)
Waist circumference 0.035
1st tertile
c 6.9 (78) 93.1 (1060)
2nd tertile 7.6 (89) 92.4 (1076)
3rd tertile 9.7 (118) 90.3 (1104)
Hypertension (medical record) < 0.001
No 4.7 (88) 95.3 (1791)
Yes 11.9 (193) 88.1 (1431)
Hypercholesterolemia (medical record) < 0.001
No 6.0 (108) 94.0 (1691)
Yes 10.2 (170) 89.8 (1501)
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to be associated with a greater risk of morbi-mortality
[38] although not as important as an ankle arm index
< 0.9. These patients were excluded from the analysis
of the associated factors to allow better comparability
among healthy patients and those with peripheral
arterial disease. This will be studied in the future.
Similar to other studies, the present series found a
higher prevalence of peripheral arterial disease in men
which progressively rose with age in both sexes. In
women, a protector effect was found with physical exer-
cise (walking >7 hours per week) and overweight,
although this was not statistically significant in men.
This protector effect of physical exercise may be justi-
fied by a greater development of collateral circulation,
which is currently one of the therapeutic recommenda-
tions in these patients. The protector effect of obesity
and overweight independent of physical exercise and
other risk factors may be surprising, but a better prog-
nosis has also been described in patients with obesity in
Table 1: Sample characteristics by peripheral arterial disease (Continued)
Blood analysis (mean ± SD)
Total cholesterol (mg/dL) 210.03 ± 42.10 216.53 ± 38.48 0.007
HDL (mg/dL) 52.30 ± 14.09 56.03 ± 14.48 < 0.001
Triglycerides (blood analysis) < 0.001
Normal 6.9 (181) 93.1 (2447)
High (≥ 150 mg/dL) 11.8 (105) 88.2 (786)
Diabetes (medical record) < 0.001
No 6.4 (191) 93.6 (2802)
Yes 17.0 (95) 83.0 (463)
Stroke (medical record) < 0.001
No 7.6 (260) 92.4 (3176)
Yes 24.4 (22) 75.6 (68)
Transient ischaemic attack (medical record) 0.001
No 7.7 (266) 92.3 (3167)
Yes 17.5 (14) 82.5 (66)
Angor (medical record) < 0.001
No 7.5 (253) 92.5 (3105)
Yes 19.0 (31) 81.0 (132)
Myocardial infarction (medical record) < 0.001
No 7.2 (245) 92.8 (3148)
Yes 29.0 (38) 71.0 (93)
Framingham index (aged≤74) < 0.001
<10 2.9 (32) 97.1 (1081)
10-20 5.5 (65) 94.5 (1120)
>20 13.0 (81) 87.0 (542)
REGICOR index (aged≤74)) < 0.001
<5 3.1 (41) 96.9 (1295)
5-10 7.0 (89) 93.0 (1177)
>10 15.0 (48) 85.0 (271)
SCORE index (aged<65) < 0.001
<2.5 2.4 (27) 97.6 (1105)
2.5-5 4.0 (18) 96.0 (427)
>5 10.9 (37) 89.1 (302)
Metabolic syndrome (NCEP) < 0.001
No 7.2 (198) 92.8 (2559)
Yes 11.4 (88) 88.6 (685)
All values are presented as prevalence of healthy and peripheral arterial disease as percent (n) unless otherwise specified. SD: standard deviation. BMI: Body mass
index expressed in Kg/m
2.
a Patients with calcification excluded.
b p value for a chi-squared test (categorical variable) and t-test (continuous variable). Fisher exact test and rank sum tests have also been performed for
categorical and continuous variables respectively leading to similar p values.
c Sex-specific tertiles. Cut points are 97 cm and 105 cm for men and 90 cm and 101 cm for women.
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Page 6 of 11Table 2 Association between peripheral arterial disease and potential risk factors. Logistic regression models adjusted
by age and sex
OR (95%CI) p-value for trend
Men 2.13 (1.65-2.75)
Age (per 10 years) 2.25 (1.96-2.60)
Education (reference = Illiterate) 0.011
Primary school 0.65 (0.42-1.00)
Secondary school 0.55 (0.31-0.99)
High school 0.48 (0.20-1.16)
University 0.29 (0.10-0.87)
Occupation status (reference = Currently working)
Housewife 1.02 (0.57-1.83)
Retired 1.14 (0.70-1.86)
Unemployed 1.10 (0.45-2.71)
Disabled 2.50 (1.29-4.88)
Other 1.76 (0.51-6.05)
Ability to perform physical activity (reference = No limitation) < 0.001
Mild limitation 2.07 (1.47-2.92)
Only able to do light activity 4.84 (3.19-7.36)
Breathless with any activity 6.70 (3.10-14.45)
Walking (hours/week) (reference = 0-3) 0.002
>3-7 0.88 (0.60-1.29)
>7 0.58 (0.40-0.82)
Tobacco smoking (reference = Never smoker) < 0.001
Former smoker 2.14 (1.45-3.17)
Current smoker 3.91 (2.58-5.93)
Claudication 5.00 (3.73-6.71)
Obesity (reference = BMI<25) 0.685
Overweight (25≤BMI<30) 0.67 (0.48-0.94)
Obese (BMI ≥30) 0.85 (0.60-1.20)
Waist circumference 0.174
2nd tertile
a 1.02 (0.73-1.41)
3rd tertile 1.23 (0.90-1.67)
Hypertension 1.99 (1.51-2.62)
Hypercholesterolemia 1.86 (1.43-2.41)
Triglycerides ≥ 150 mg/dL 2.05 (1.58-2.66)
Diabetes 2.39 (1.82-3.15)
Stroke 2.92 (1.74-4.90)
Transient ischaemic attack 1.73 (0.93-3.20)
Angor 1.90 (1.23-2.93)
Myocardial infarction 3.81 (2.50-5.82)
Framingham index (aged≤74) < 0.001
10-20 1.42 (0.88-2.29)
>20 2.57 (1.49-4.43)
REGICOR index (aged≤74) < 0.001
5-10 1.60 (1.05-2.43)
>10 2.61 (1.55-4.38)
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infarction [39,40]. However, we did not find any rela-
tionship with waist circumference, although on adjusting
for the body mass index (BMI) we did find a relation-
ship with the second [OR 1.25 (0.87-1.81)] and the third
tertile [OR 1.56 (1.02-2.37)] compared to the first tertile,
which disappeared on adjustment for the remaining
variables in the multivariate model.
With regard to studies evaluating the association with
different factors, our results coincide in age [8-13], male
gender [8-13], hypertension [9-11], diabetes [11,12],
smoking [10-12], and history of cardiovascular disease
[9,10]. In the present study we found an association
with hypercholesterolemia and hypertriglyceridemia in
women. In other studies [11,12], an association has also
been reported with hypercholesterolemia, while the
results related to triglycerides in the literature are con-
tradictory [9].
With respect to limitations of the study, as usually
occurs in population-based studies in Spain, women
were slightly over-represented [14]. Although the data
from the census were not used, in Spain the use of the
population assigned to the primary care centres is pre-
ferable since it is more exhaustive and updated than
that of the census [41]. On the other hand, the cross-
sectional design of the study did not allow determina-
tion of the causal effect of the different factors asso-
ciated with peripheral arterial disease.
The technical ease of the ankle-arm index and it ready
adoption in the primary care offices has replaced the use
of carotid echo-Doppler for detecting patients with high
cardiovascular risk. However, a large proportion of the
population has an intermediate risk, thus it remains to
be defined in which patients ankle arm index should be
a priority. According to the present study these patients
would include: males, aged over 60 years, smokers or
Table 3 Association between peripheral arterial disease and potential risk factors. Multivariate logistic regression
models by sex.
Total Men Women
OR (95%CI) OR (95%CI) OR (95%CI)
Men 1.62 (1.01-2.59)
Age (×10 years) 2.00 (1.64-2.44) 1.83 (1.42-2.36) 2.17 (1.52-3.09)
PA Mild limitation
a 1.77 (1.17-2.68) 2.16 (1.33-3.51) 0.92 (0.42-2.03)
PA Only able light activity
a 3.64 (2.16-6.13) 4.09 (2.12-7.91) 2.39 (0.97-5.90)
PA Breathless any activity
a 7.08 (2.61-19.2) 7.47 (1.87-29.8) 5.40 (1.14-25.7)
>7 h/w walking
b 0.67 (0.49-0.94) 0.82 (0.55-1.23) 0.43 (0.22-0.82)
Former smoker
c 2.19 (1.34-3.58) 2.48 (1.26-4.90) 1.47 (0.52-4.11)
Current smoker
c 3.83 (2.23-6.58) 4.18 (2.01-8.69) 4.00 (1.59-10.1)
BMI ≥25 Kg/m
2 0.57 (0.38-0.87) 0.65 (0.39-1.08) 0.43 (0.20-0.92)
Hypertension 1.85 (1.29-2.65) 1.78 (1.16-2.72) 2.03 (0.99-4.149
Hypercholesterolemia 1.55 (1.11-2.18) 1.36 (0.90-2.07) 1.87 (1.03-3.40)
High triglycerides 1.55 (1.10-2.19) 1.27 (0.82-1.98) 2.29 (1.29-4.05)
Diabetes 2.01 (1.42-2.83) 2.27 (1.50-3.44) 1.59 (0.85-2.99)
Cardiovascular disease 2.19 (1.52-3.15) 2.54 (1.66-3.90) 1.43 (0.67-3.02)
Patients with calcification excluded.
All models adjusted for the variables included in the table and centre.
PA: Physical activity (reference = No limitation), BMI: Body mass index
a p for trend are < 0.001 (total and men) and 0.009 (women) for physical activity.
bReference = less than or equal to 7 hours walking per week
c p for trend are < 0.001 (total and men) and 0.003 (women) for smoking.
Table 2: Association between peripheral arterial disease and potential risk factors. Logistic regression models adjusted
by age and sex (Continued)
SCORE index (aged<65) < 0.001
2.5-5 1.43 (0.71-2.89)
>5 3.99 (2.00-7.95)
Metabolic syndrome (NCEP) 1.79 (1.36-2.36)
Patients with calcification excluded.
All models adjusted for age, sex and centre.
BMI: Body mass index.
aSex-specific tertiles. Cut points are 97 cm and 105 cm for men and 90 cm and 101 cm for women.
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Page 8 of 11ex-smokers, those with clinical manifestations of IC or
difficulty in performing physical activity, patients with
hypertension, diabetes or hypertriglyceridemia. The
addition of ankle-arm index in prediction tables of car-
diovascular risk can improve the sensitivity and positive
predictive values, especially in patients with intermediate
or low cardiovascular risk.
Conclusions
In summary, the prevalence of peripheral arterial disease
in our population of low-medium risk is lower com-
pared to studies carried out in countries of high risk.
Our results coincide with most of the studies published
on risk factors for peripheral arterial disease, but the
protector effect of physical exercise and overweight is of
note. It is necessary to determine the prognostic value
of peripheral arterial disease compared to cardiovascular
disease in a longitudinal study and to define the popula-
tion in whom the use of the ankle arm index should be
a priority to thereby correctly stratify the cardiovascular
risk of our population beyond the use of the tables for
risk of cardiovascular disease. Further studies are
required to clarify the clinical significance and the asso-
ciation with cardiovascular risk of patients with arterial
calcification and those in whom the ankle arm index
cannot be determined.
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